Concepedia

Jason Godfrey

JG

Statistics

Publications

5

Citations

747

H-Index

5

Active since

2012

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Boston University

Dana-Farber Cancer Institute

Jason Godfrey is an author at Massachusetts General Hospital specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2012–2024

5

Publications

5

Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models

Ryan B. Corcoran, Katherine A. Cheng, Aaron N. Hata et al. · Cancer Cell · 2012 · 379 citations · Full text

, , +17

Inhibition of <i>KRAS</i> -Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit

Zehua Zhu, Amir Reza Aref, Travis J. Cohoon et al. · Cancer Discovery · 2014 · 193 citations · Full text

, , +15

Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in <i>BRAF</i> -Mutant Colorectal Cancer

Daniele Oddo, Erin M. Sennott, Ludovic Barault et al. · Cancer Research · 2016 · 122 citations · Full text

, , +17

Auxin and Tryptophan Homeostasis Are Facilitated by the ISS1/VAS1 Aromatic Aminotransferase in <i>Arabidopsis</i>

Michael Pieck, Youxi Yuan, Jason Godfrey et al. · Genetics · 2015 · 32 citations · Full text

, , +17

Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell Carcinoma

Romain Riscal, Sarah M. Gardner, Nathan J. Coffey et al. · Cancer Research · 2024 · 21 citations · Full text

, , +17

1–5 of 5